Preclinical evaluation of autologous dendritic cells transfected with mRNA or loaded with apoptotic cells for immunotherapy of high-risk neuroblastoma.
about
A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines.RESEARCH ADVANCES IN NEUROBLASTOMA IMMUNOTHERAPY.Personalized dendritic cell-based tumor immunotherapy.Antitumor Vaccines Based on Dendritic Cells: From Experiments using Animal Tumor Models to Clinical Trials.Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications.
P2860
Preclinical evaluation of autologous dendritic cells transfected with mRNA or loaded with apoptotic cells for immunotherapy of high-risk neuroblastoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Preclinical evaluation of auto ...... py of high-risk neuroblastoma.
@en
type
label
Preclinical evaluation of auto ...... py of high-risk neuroblastoma.
@en
prefLabel
Preclinical evaluation of auto ...... py of high-risk neuroblastoma.
@en
P2093
P2860
P50
P356
P1433
P1476
Preclinical evaluation of auto ...... py of high-risk neuroblastoma.
@en
P2093
Finn Wesenberg
Mette R K Olafsen
Rolf D Pettersen
Silvija Jarnjak-Jankovic
Stein Saebøe-Larssen
P2860
P2888
P304
P356
10.1038/SJ.CGT.7700820
P577
2005-08-01T00:00:00Z
P6179
1017100771